Xarelto Lawsuit Attorney
Dallas W. Hartman P.C. is currently reviewing cases against the manufactures of Xarelto. Patients who took Xarelto as indicated and suffered a major bleeding event, stroke, or death could be eligible for legal action against the drug’s manufacturers. Also potentially eligible are the family members of a patient who died while taking Xarelto. Contact our team of specialized dangerous drugs attorneys in Pittsburgh for legal representation if you have been injured from Xarelto.
Xarelto Linked to Serious Bleeding Events, Stroke and Death
The blood thinning drug Xarelto (rivaroxaban) has recently been linked to serious bleeding events and including several deaths. Xarelto was approved by the U.S. Food and Drug Administration (FDA) in 2011. It is supposed to reduce the risk of strokes, deep vein thrombosis (DVT), pulmonary embolism (PE), and blood clots.
Xarelto was highly promoted as the replacement for older blood thinners like Warfarin, but it has been shown to cause bleeding that cannot be stopped by doctors. Xarelto lawsuits are similar to lawsuits over Pradaxa, another newer-generation anticoagulant. Thousands of Pradaxa lawsuits were filed and consolidated in federal court, and millions of dollars in compensation were awarded to victims.
FDA Doubts About Xarelto’s Approval
Before its approval in 2011, some FDA scientists had misgivings about approving Xarelto due to a perceived lack of care in clinical trial design. FDA reviewers concluded that patients could be put at greater risk of harm from stroke and/or bleeding when treated with Xarelto, compared to careful treatment with traditional blood thinners. In one clinical trial of Xarelto compared to Warfarin, 30 days after the study ended subjects that took the Xarelto experienced 22 strokes, while subjects that took the Warfarin experienced only 6 strokes.
Xarelto is different from earlier anticoagulants in important ways. First, it does not have an antidote to stop internal bleeding side effects. Second, it does not require regular blood monitoring tests that may help prevent uncontrolled bleeding. Despite over a thousand lawsuits, Xarelto has not been recalled. Doctors are still prescribing the drug to patients despite its potential to cause harm. In 2014 alone, Xarelto brought in $1.5 billion in U.S. sales.
Lawsuits have been filed claiming Xarelto has caused:
- Death
- Stroke
- Excessive Blood Loss
- Wound Infection and Complication
- Intracranial Hemorrhages
- Abdominal Hemorrhages
- Adrenal Bleeding
- Retinal Hemorrhages
- Epidural Hematoma
Claimants allege that its lack of an antidote constitutes a design defect and that the drug does not provide greater patient benefits than drugs like Warfarin, which were safely administered for decades. Some claimants allege that Janssen/Bayer intentionally concealed knowledge of Xarelto’s irreversible, life-threatening bleeding.
Contact Our Injury Attorneys for a Free Xarelto Case Evaluation
If you or a loved one took Xarelto and experienced any complications, it’s not too late to seek help from our Pittsburgh personal injury attorneys. Please call our experienced defective drug lawyers at 800-777-4081 or email us now.